<DOC>
	<DOCNO>NCT01978015</DOCNO>
	<brief_summary>Glaucoma , progressive optic disc neuropathy cause visual field reduction , second lead cause world blindness . The treatment glaucoma mainly base reduce intraocular pressure ( IOP ) topical medication . Many patient require two medication achieve target IOP . Combinations B-blockers prostaglandin analog ( PGA ) frequently use clinical practice additive effect lower IOP level . The aim study investigate effect fix combination timolol maleate PGA blood-aqueous barrier evaluate measurement foveal thickness pseudophakic patient primary open-angle glaucoma ( POAG ) .</brief_summary>
	<brief_title>Blood-aqueous Barrier Changes After Use Timolol Prostaglandin Analogues Fixed Combination Pseudophakic Patients With POAG</brief_title>
	<detailed_description>Most study find low incidence systemic ocular adverse event fix combination unfixed combination . Fixed combination well tolerate respective prostaglandin analogue . However , among serious side effect induce PGA break blood-aqueous barrier ( BAB ) development cystoids macular edema ( CME ) . Also , timolol maleate drop increase protein concentration human benzalkonium chloride , eye drop preservative induces anterior chamber inflammation . This randomized , masked-observer , prospective clinical trial approve Ethics Committee University Campinas , adhere tenet Declaration Of Helsinki . Written inform consent obtain patient .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis , Anterior</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Cloprostenol</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Patients eligible participation meet follow inclusion criterion : age old 18 year , pseudophakia diagnosis primary open angle glaucoma ( untreated IOP level 21 mmHg , specific change optic disc specific visual field change . Optic disc change focal notching , optic disc haemorrhage , retinal nerve fiber layer ( RNFL ) defect , overpassblood vessel cross area neuroretinal rim loss.Visual field change glaucoma hemifield test outside normal limit cluster three nonedge point typical location glaucoma correct pattern standard deviation occur less 5 % normal visual field Exclusion criterion include history uveitis CME , substantial ocular irritation baseline , history intraocular surgery laser procedure within 6 month baseline , presence systemic disorder could associate uveitis CME ( ie , diabetes mellitus rheumatologic disease ) , presence agerelated macular degeneration macular disease , pregnancy , breastfeeding , inadequate contraception ( female ) , treatment systemic betablocker , history bronchial asthma , chronic obstructive pulmonary disease , sinus bradycardia , second third degree atrioventricular block , sinoatrial block functionally significant visual field loss</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>primary open angle glaucoma</keyword>
	<keyword>timolol</keyword>
	<keyword>prostaglandin analogue</keyword>
</DOC>